IRIS
AVERSA, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 13.983
NA - Nord America 13.705
EU - Europa 7.232
SA - Sud America 1.652
AF - Africa 662
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 8
Totale 37.264
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.251
SG - Singapore 5.329
CN - Cina 3.770
VN - Vietnam 1.782
IE - Irlanda 1.492
BR - Brasile 1.301
IT - Italia 1.165
HK - Hong Kong 1.010
SE - Svezia 914
FI - Finlandia 903
DE - Germania 779
TR - Turchia 698
BD - Bangladesh 648
ZA - Sudafrica 485
UA - Ucraina 434
FR - Francia 432
NL - Olanda 406
CA - Canada 319
GB - Regno Unito 189
RU - Federazione Russa 177
AR - Argentina 143
IN - India 135
IQ - Iraq 87
JP - Giappone 82
MX - Messico 74
AT - Austria 69
PL - Polonia 56
KR - Corea 51
EC - Ecuador 49
PH - Filippine 47
BE - Belgio 45
ES - Italia 39
ID - Indonesia 39
PK - Pakistan 39
VE - Venezuela 39
UZ - Uzbekistan 38
TH - Thailandia 35
CO - Colombia 32
CI - Costa d'Avorio 30
SA - Arabia Saudita 30
MA - Marocco 28
EG - Egitto 26
PY - Paraguay 26
CZ - Repubblica Ceca 24
EU - Europa 22
RO - Romania 21
TW - Taiwan 21
KE - Kenya 19
LT - Lituania 19
CL - Cile 18
JO - Giordania 16
PE - Perù 15
IL - Israele 14
SN - Senegal 12
BO - Bolivia 11
DZ - Algeria 11
OM - Oman 11
UY - Uruguay 11
NP - Nepal 10
PA - Panama 10
AE - Emirati Arabi Uniti 9
AL - Albania 9
AZ - Azerbaigian 9
ET - Etiopia 9
KZ - Kazakistan 9
CR - Costa Rica 8
GT - Guatemala 8
JM - Giamaica 8
MY - Malesia 8
IR - Iran 7
KG - Kirghizistan 7
PS - Palestinian Territory 7
TN - Tunisia 7
BG - Bulgaria 6
GR - Grecia 6
DO - Repubblica Dominicana 5
GY - Guiana 5
NG - Nigeria 5
PT - Portogallo 5
QA - Qatar 5
SI - Slovenia 5
AO - Angola 4
AU - Australia 4
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
BY - Bielorussia 4
CH - Svizzera 4
GA - Gabon 4
HN - Honduras 4
KH - Cambogia 4
RS - Serbia 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BN - Brunei Darussalam 3
CG - Congo 3
CM - Camerun 3
DK - Danimarca 3
HU - Ungheria 3
LB - Libano 3
LY - Libia 3
Totale 37.203
Salva come PNG Salva come JPEG
Città #
Singapore 2.512
Dublin 1.492
Chandler 1.468
San Jose 1.403
Ashburn 1.338
Beijing 1.017
Hong Kong 971
Jacksonville 908
Izmir 623
Ho Chi Minh City 530
Santa Clara 530
Dallas 527
Nanjing 480
Johannesburg 461
Boardman 428
Hanoi 413
Dearborn 382
Princeton 352
San Mateo 330
New York 327
Lauterbourg 313
Parma 303
Los Angeles 255
Ann Arbor 236
Wilmington 235
Columbus 234
Toronto 195
Helsinki 158
Shenyang 154
Shanghai 149
Kunming 144
Nanchang 141
The Dalles 141
Moscow 135
Council Bluffs 117
Hebei 115
São Paulo 111
Buffalo 105
Jinan 100
Munich 97
Hefei 96
Changsha 93
Des Moines 93
Tianjin 86
Haiphong 81
Jiaxing 80
Milan 74
Da Nang 72
Rome 72
Tokyo 64
Düsseldorf 59
Guangzhou 56
Vienna 56
San Francisco 49
Seattle 47
Frankfurt am Main 46
Norwalk 46
Bologna 44
Orem 43
Turku 42
Warsaw 39
Montreal 38
Brooklyn 37
Chicago 37
Brussels 36
Hangzhou 36
Atlanta 35
Rio de Janeiro 35
Tashkent 35
Hải Dương 34
London 34
Boston 32
Belo Horizonte 31
Zhengzhou 31
Chennai 30
Abidjan 29
Chengdu 29
Kocaeli 29
Biên Hòa 28
Brasília 28
Woodbridge 28
Marseille 27
Stockholm 27
Jakarta 26
Charlotte 25
Falls Church 24
Naples 24
Bremen 23
Denver 23
Houston 23
Seoul 23
Baghdad 22
Dhaka 22
Phoenix 22
Mestre 21
Mexico City 21
Fremont 20
Haikou 20
Wuhan 20
Campinas 19
Totale 22.352
Salva come PNG Salva come JPEG
Nome #
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 256
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 228
Ammonium Production and Glutamine-Addiction of Myeloma Cells: New Attractive Targets in Multiple Myeloma 221
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target 220
The -2518 A/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and biomarker of disease severity 208
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 204
Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients. 203
Neurofibromatosis type I and multiple myeloma coexistence: A possible link? 203
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis 199
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors 194
The Proteasome and Myeloma-Associated Bone Disease 191
Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma 188
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo 185
Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML 184
Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20 183
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation 182
Sindrome preleucemica 180
The -2518 A/G single nucleotide polymorphism of MCP-1 in myelofibrosis: functional characterization on ex-vivo patient cells. 180
Hypoxia-Inducible Factor (HIF)-1 alpha Inhibitionin Myeloma Cells Significantly Increases the Anti-Myeloma Effect of Lenalidomide in Vivo 179
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC 179
IN VITRO CHARACTERISTICS OF HEMATOPOIETIC PROGENITORS FROM PRIMARY MYELOFIBROSIS PATIENTS CORRELATE WITH IPSS/DIPSS RISK CATEGORY 176
EXPRESSION OF CD38 AND ECTOENZYMES OF THE ADENOSINERGIC PATHWAYS IN MYELOMA BONE NICHE: A RATIONAL BASIS FOR THE USE OF DARATUMUMAB TO TARGET OSTEOCLAST FORMATION IN MULTIPLE MYELOMA 174
PROTEIN KINASE Ce EXPRESSION IN PRIMARY MYELOFIBROSIS PLATELETS CORRELATES WITH CARDIOVASCULAR EVENTS 169
Addition of Bortezomib to High Dose Melphalan As Conditioning Regimen for Autologous Stem Cell Transplantation Improves the Response Rate in Newly Diagnosed Multiple Myeloma Patients 168
''Designed'' grafts for HLA-haploidentical stem cell transplantation 165
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. 164
ERK1/2 is the signaling pathway primarily activated in myeloid neoplasms carrying t(8;9)/PCM1-JAK2 fusion. A two cases report. 164
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 161
Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression 160
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 159
Bortezomib improves bone integrity in multiple myeloma patients by blocking osteocyte death and autophagy 159
DEPENDENCE ON GLUTAMINE UPTAKE OF MYELOMA CELLS DELINEATES A NEW ATTRACTIVE THERAPEUTIC STRATEGY 159
Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin? 157
LENALIDOMIDE INCREASES HUMAN DENDRITIC CELL MATURATION MODULATING BOTH MONOCYTE DIFFERENTIATION AND MESENCHYMAL STROMAL CELL INHIBITORY PROPERTIES 157
[Evaluation of the immunological status of patients with Hodgkin's disease] 155
A prospective survey of febrile events in hematological malignancies 155
Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells 154
Protein kinase Cɛ inhibition restores megakaryocytic differentiation of hematopoietic progenitors from primary myelofibrosis patients 154
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 154
GOOD IMMUNOLOGICAL RECONSTITUTION IN ADULTS WITH ACUTE LEUKEMIA AFTER.LFA-BETA TCR/CD19+DEPLETED HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) 153
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 153
Expression Profile of CD38 and Related Ectoenzymes in Myeloma Bone Niche: A Rational Basis for the Use of Daratumumab to Inhibit Osteoclast Formation and Activity 153
Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. 152
Platelet expression of PKCepsilon oncoprotein in myelofibrosis is associated with disease severity and thrombotic risk 150
Back to the future: mismatched unrelated donor, haploidentical related donor, or unrelated umbilical cord blood transplantation? 149
[Sequential polychemotherapeutic treatment of inoperable bronchogenic carcinoma] 148
Galectin-1 Is Highly Expressed By Myeloma Cells and the Bone Marrow Microenvironment and Its Suppression Delineates a New Therapeutic in Vitro and in Vivo Strategy in Multiple Myeloma 148
Acquisition of Ig isotype diversity after bone marrow transplantation in adults. A recapitulation of normal B cell ontogeny. 147
The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells 147
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties 146
Lung damage following bone marrow transplantation after hyperfractionated total body irradiation. 145
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 144
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia. 144
TLR3 essentially promotes protective class I-restricted memory CD8⁺ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. 144
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. 141
Bone marrow CD14+ cells show different transcriptional profiles in Multiple Myeloma (MM) as compared to smoldering MM and MGUS: overexpression of IL21R and its involvement in osteoclastogenesis 141
Acute lymphoblastic leukaemia in Noonan syndrome. 141
The link between bone microenvironment and immune cells in multiple myeloma: Emerging role of CD38 140
PCM1-JAK2 Fusion Product Selectively Activates MAP-Kinase Pathway and Fails to Phosphorylate JAK2 and STAT5: Implications for Therapeutic Strategies. 139
The osteoblastic niche in the context of multiple myeloma 138
A prospective, multicentre survey on antifungal therapy in neutropenic paediatric haematology patients. 138
Haploidentical stem cell transplantation after negative depletion of T cells expressing the alfabeta chain of the T-cell receptor (TRC) for adults with haematological malignamcies 135
Serie granulocitaria 134
Primary Prophylaxis of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Revised Recommendations from a Consensus Process by Gruppo Italiano Trapianto Midollo Osseo (GITMO) 134
A multidrug-resistant Pseudomonas aeruginosa isolate from a lethal case of sepsis induces necrosis of human neutrophils. 134
Lenalidomide Increases Human Dendritic Cell Maturation in Multiple Myeloma Modulating Both Monocyte Differentiation and Mesenchymal Stromal Cell Inhibitory Properties through Ikaros and Casein Kinase 1 Degradation, Respectively 134
Etiology of febrile episodes in patients with acute myeloid leukemia: results from the Hema e-Chart Registry 133
Human thrombopoiesis depends on PKCdelta/PKCepsilon functional couple 133
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 130
Allogeneic Hematopoietic stem cell transplantation and natural killer cell alloreactivity, 130
Protein Kinase C Epsilon Inhibition Restores In-Vitro Megakaryocyte Differentiation Of Primary Myelofibrosis Hematopoietic Progenitors 130
T cell depleted haploidentical transplantation: positive selection. 129
Oncolytic Virotherapy in Multiple Myeloma: A Possible Alternative Role of Bovine Viruses 129
Microbiota control of a tryptophan–AhR pathway in disease tolerance to fungi 129
Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation. 128
Hema e-Chart: Italian Registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies. 127
Mieloma multioplo ed altre discrasie linfoplasmacellulari 126
Amphotericin B lipid complex in the management of invasive fungal infections in immunocompromised patients 126
A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients. 126
The anti-myeloma effect of Lenalidomide is increased by hypoxia-inducible factor (HIF)-1a inhibition in multiple myeloma cells both in vitro and in vivo 126
Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamide 126
Hypoxia-inducible factor (HIF)-1 is a therapeutic target in myeloma-induced angiogenesis and bone destruction in vitro and in vivo 125
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations 125
Baseline factors associated with response to ruxolitinib: An independent study on 408 patients with myelofibrosis 124
Allogeneic transplants of rhG-CSF-mobilized peripheral blood stem cells (PBSC) from normal donors. GITMO. Gruppo Italiano Trapianto di Midollo Osseo. 123
T cell depleted HLA-identical bone marrow transplants 123
Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation. 122
[T-cell depletion today: pros and cons] 122
BORTEZOMIB WITH HIGH DOSE MELPHALAN CONDITIONING FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IS SAFE AND IMPROVES THE RESPONSE RATE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA 122
Amiloidosi 121
Allogeneic transplantation across the HLA barriers. 121
Therapeutic Strategy for Elderly Patients with ACUTE Myeloid Leukemia (AML) Carrying the DNMT3A Mutation 121
Non-B, non-T acute lymphoblastic leukaemia terminating in malignant histiocytosis: a new case and a review of the literature. 120
The haploidentical option for high-risk haematological malignancies. 120
T Cell Responses in Fungal Infections 119
Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia in the ATRA and ATO era 119
Peripheral blood progenitor cell mobilization in healthy donors receiving recombinant human granulocyte colony-stimulating factor. 119
Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma 119
Favorable clinical outcome and response to immunotherapy share a common PD-L1/PD-1 based NSCLC immune contexture 119
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 117
Totale 15.132
Salva come PNG Salva come JPEG
Categoria #
all - tutte 132.432
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.432
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 0 0 23
2021/20221.512 19 15 17 64 45 28 170 257 62 197 85 553
2022/20235.299 688 350 244 381 463 586 60 352 1.913 35 165 62
2023/20241.800 128 230 53 60 155 515 68 116 25 68 144 238
2024/20256.419 62 398 520 413 640 424 182 367 838 627 605 1.343
2025/202614.381 1.107 1.277 1.810 1.038 2.185 781 1.812 455 1.652 931 785 548
Totale 37.569